Page 146 - 20211214_OHKF_Health_Finance_Research_Report_E (1)
P. 146

Box 4.4

                   Rationale of measuring willingness-to-pay (WTP) of
                   prospective participants of the Scheme



                   While the Scheme intends to fully subsidise the cost of screening for all
                   eligible patients, chronic disease management could incur costs through
                   co-payment by scheme subscribers. Currently, a follow-up consultation for
                   chronic disease patients with stable conditions at the Hospital Authority (HA)
                   General Out-patient Clinics (GOPCs) costs HKD 50. In comparison, the
                   private sector does not currently offer sufficient price transparency nor
                   standardised price points across all providers. As such, estimating
                   prospective users’ WTP for each consultation to manage
                   chronic conditions is imperative in designing a voucher
                   scheme that encourages public uptake. While we acknowledge
                   that assessing the maximum WTP per respondent may be insufficient in
                   capturing the affordability of pricing, especially given that willingness may
                   not equate to financial capacity, a WTP range will help voucher designers
                   and policymakers best structure payment schemes.




            4.2.2 FACTORING IN ACCESSIBILITY AS A KEY
                    CONSIDERATION TO ENGAGE IN REGULAR
                    SCREENING AND MANAGEMENT OF CHRONIC
                    CONDITIONS

            Ever more presently, health system sustainability is being threatened by rising demand and
            disproportionate resource allocation. In Chapter 1, we discussed that health financing
            systems have set universal health coverage (UHC) as a main policy priority. In parallel,
            universal access, which encompasses physical accessibility, financial affordability, and
            acceptability, must also exist to facilitate progress towards UHC (Evans et al., 2013).
            We believe that the Scheme will be successful if implemented with the
            necessary factors for universal access, and ultimately UHC, in mind.

            “Universal access”, as defined by the World Health Organisation (WHO), is comprised of
            three interlinked dimensions (Figure 4.1):

            •  Physical accessibility, which relates to the availability of quality health services within
               reach of individuals in relation to service organisation and delivery;
            •  Financial affordability, which is based upon an individual’s ability to afford services,
               including both direct and indirect costs to patients;
            •  Acceptability, which captures individuals’ willingness to seek and receive services
               (Evans et al., 2013).
















       144
   141   142   143   144   145   146   147   148   149   150   151